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TRAUMA AND PSYCHOPHYSIOLOGIC REACTIVITY: MENSTRUAL PHASE, 
POSTTRAUMATIC STRESS DISORDER, AND PERFORMANCE ON A LOUD 
TONES TASK 
ANELINE AMALATHAS 
 
ABSTRACT 
 
The current study examines the effects of Posttraumatic Stress Disorder (PTSD) 
and menstrual cycle phase on psychophysiologic reactivity to a loud tones task in a 
population of female trauma survivors. Estradiol and progesterone fluctuate throughout 
the menstrual cycle; prior research has shown the variety of effects these hormones have 
on the Hypothalamic-Pituitary Adrenal (HPA) axis, glucocorticoids, stress and anxiety 
homeostasis, and conditionability. We hypothesized greater reactivity for participants 
with PTSD, and that menstrual cycle would moderate the effects of PTSD and 
performance on the loud tones task. Results indicated heart rate was higher in participants 
in the mid-luteal phase than early follicular phase. Several results were surprising, 
including that participants with PTSD demonstrated less startle reactivity and faster 
habituation (as measured using the left orbicularis electromyogram (O-EMG) measure) 
than participants in the trauma control group for. Considerations are made for 
demographics, sample size, and the number of potential underlying mechanisms for 
PTSD. 
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INTRODUCTION 
 
 
 
POSTTRAUMATIC STRESS DISORDER 
 
Since the mid-1800s, Posttraumatic Stress Disorder (PTSD) has borne a number 
of names. Prior to this time, soldiers sometimes experienced “nostalgia” – missing home, 
sleep problems, and anxiety, among other symptoms. This formed the basis of a 
psychological injury model for understanding these symptoms in Civil War soldiers. 
Models based on the physical components of post-trauma reactions (e.g., rapid pulse, 
anxiety, and trouble breathing) gave rise to other terms, such as soldier’s heart, railroad 
spine, and shell shock, which was specific to World War One. A variety of treatments 
were attempted, including hypnosis and electrotherapy. During World War Two, the shell 
shock diagnosis became known as Combat Stress Syndrome, or battle fatigue, due to long 
campaigns. While some doubted the affliction’s existence, the U.S. military worked to 
treat those suffering from battle fatigue promptly in an effort to help soldiers return to the 
front lines (“History of PTSD”, 2015). 
In 1952, the first Diagnostic and Statistical Manual-I (DSM-I) was developed for 
use in assessment and diagnosis of mental health problems. In the DSM-I, the condition’s 
name changed yet again to “gross stress reaction,” and now included civilians among 
those who could be affected. With the DSM-II, the diagnosis was eliminated and replaced 
with “adjustment reaction to adult life,” a highly limited substitute that didn’t capture the 
qualities of PTSD like its predecessors. The term “Posttraumatic Stress Disorder” was 
first used after the Vietnam War. This term described soldiers returning from combat, 
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Holocaust survivors, sexual assault victims, and others who exhibited hyperarousal, 
nightmares, flashbacks, and re-experiencing in an intrusive and distressing manner 
(“History of PTSD in Veterans”, 2015). 
PTSD was first found in the third edition of the DSM in 1980 (DSM-III). 
 
Depression and anxiety were listed as common comorbid diagnoses, along with other 
features such as compulsive behaviors, pseudo-organic symptoms, and survivor’s guilt. 
Since then, PTSD has undergone revisions throughout later editions of the DSM, the 
DSM-IV, DSM-IV-TR, and DSM-5. Once categorized as an anxiety disorder, in the 
DSM-5 PTSD is now listed in a separate category, Trauma- and Stressor-Related 
Disorders (“History of PTSD in Veterans”, 2015). According to the DSM-5, there are 
four primary types of symptoms: reliving the event (re-experiencing), avoiding situations 
that remind one of the event, negative changes in beliefs and feelings, and hyperarousal 
(“Symptoms of PTSD”, 2015). 
This is by no means a recent phenomenon. Abdul-Hamid and Hughes (2014) 
notes Herodotus’ account of Epizelus, an Athenian spear carrier at the battle of Marathon, 
which is considered to be the first documented case of PTSD in historical literature, but 
provides evidence of much earlier accounts primarily from Mesopotamia. The 
Mesopotamians valued the power of diagnosis: they often believed disease was the result 
of the gods’ displeasure with the patient via demons or spirits invading them. Though 
counterintuitive, this is closer to the modern concept of foreign bodies infecting patients 
than the Greek notion of bodily humors being imbalanced. Symptoms of hyperarousal, 
avoidance, flashbacks and re-experiencing, and cognitive changes were described in the 
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extensive military records of the Mesopotamians, for whom military service was required 
of the male population. The symptoms were attributed to “roving” or “roaming” ghosts 
that altered the mental state and caused a “wandering mind.” 
PTSD is frequently associated with combat and war veterans, but civilians are 
afflicted as well. According to the Department of Veteran Affairs, recent data shows just 
how common PTSD is: 4% of men and 10% of women will develop PTSD in their 
lifetime (“History of PTSD in Veterans”, 2015). Breslau et al. (1998) studied a survey of 
2182 residents of Detroit in 1996 and found that while women were half as likely as men 
to be exposed to assaultive violence and other injury or shock trauma types, women were 
found to be more than two times as likely to develop PTSD after exposure as men: 13.0% 
versus 6.2%, respectively. In terms of duration, 26% of individuals with PTSD diagnoses 
remitted by 6 months and 40% remitted by 12 months. When broken down by sex 
however, PTSD in women lasted four times as long as in men (48.1 months compared to 
12.0 months, respectively). The authors concluded that sex is a significant risk factor for 
developing and maintaining PTSD. 
MENSTRUAL CYCLE 
 
Considering sex differences in PTSD, one significant difference between men and 
women comes to mind: the menstrual cycle. Beginning at puberty, women typically 
follow approximately a 28- to 32-day cycle until menopause occurs, starting between the 
ages of 45 and 55. 
The hormonal component of the menstrual cycle can be broken down into the 
luteal and the follicular phases, named for the prevalence of follicular stimulating 
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hormone (FSH) and luteinizing hormone (LH). A surge of luteinizing hormone around 
day 12 of a standard 28 day cycle results in ovulation. The ovum is released from the 
ovary into the oviduct and travels toward the uterus. If it is not fertilized by a sperm, the 
ovum does not implant in the uterine wall and is expelled with the shedding uterine lining 
at menstruation. The corpus luteum is formed upon release of the ovum from the ovary 
and produces the hormones estrogen and progesterone. These hormones reach their 
highest levels together during the mid-luteal phase (mLP). Once the corpus luteum 
atrophies, estrogen and progesterone levels drop; progesterone helps maintain the uterine 
lining and, with this decrease, menstruation begins. During the early follicular phase 
(eFP), estrogen and progesterone levels are at their lowest points during the cycle (see 
Figure 1). 
 
 
Figure 1: The menstrual cycle. Nillni, Toufexis, and Rohan, (2011). 
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Research on the interaction of PTSD and the menstrual cycle is still fairly limited. 
 
Literature shows women with PTSD experiencing increased levels of depression and 
phobic anxiety during the early follicular phase compared to the mid-luteal phase (Nillni, 
et al., 2015). This finding suggests low estrogen and progesterone levels may affect 
emotion and fear regulation. Glover et al. (2012) found hormonal status, specifically low 
estrogen, influences fear inhibition in both healthy and traumatized participants, which 
supports the idea of estrogen and progesterone having a role in anxiety regulation. In a 
study by Nillni et al. (2015) women with PTSD in the eFP demonstrated higher anxiety 
than during the mLP. Bryant et al. (2011) studied the association of the menstrual cycle 
and traumatic memories, concluding that women who experienced the initial trauma 
during the luteal phase were 3.68 times more likely to experience flashbacks. The study 
also found those who were in the luteal phase during the study were 4.89 times more 
likely to experience flashbacks than those in the follicular phase during the study. Trauma 
experienced during the luteal phase may be encoded in memory more strongly than 
during the follicular phase. Thus, there is emerging support for the possibility of PTSD 
being influenced by the menstrual cycle and associated hormone levels. 
Possible mechanisms for this association involve several components: 
progesterone, allopregnanolone and its derivatives (collectively termed ALLO), and γ- 
aminobutyric acid (GABA). ALLO is a metabolite of progesterone by a two-step 
enzymatic pathway (see Figure 2). ALLO acts as a potent allosteric agonist of the 
GABAA receptor, which is found in the central nervous system, and GABA acts as the 
primary inhibitory neurotransmitter. Following ovulation, progesterone peaks in the mid- 
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luteal phase. In healthy individuals ALLO levels subsequently increase during the mLP, 
which then binds to GABAA and promotes inhibition in the central nervous system. Once 
the corpus luteum degrades at the end of the luteal phase and menstruation begins, 
progesterone rapidly decreases. The subsequent abrupt drop in ALLO may produce an 
anxiogenic effect rather than its usual anxiolytic effect (Nillni, Toufexis, & Rohan, 2011). 
This is a window of vulnerability with regard to developing PTSD and other anxiety 
disorders. 
 
 
Figure 2: Progesterone synthesis and metabolism. Schumacher, Hussain, Gago, Oudinet, 
Mattern, and Ghoumari (2012). 
Another possible mechanism involves these same components in the context of 
glucocorticoids. Progesterone causes increased glucocorticoid release by acting as a weak 
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agonist of the glucocorticoid receptor (Lei et al., 2012; Attardi et al., 2008; Bryant et al., 
2011). There is evidence that glucocorticoids play a role in memory encoding and that 
there is increased glucocorticoid release during the luteal phase as a result of increased 
progesterone levels. Trauma experienced then, particularly in the mLP, is more likely to 
be encoded for this reason. Bryant et al. (2011) suggest this is due to progesterone 
stimulating glucocorticoids during the traumatic event taking place during the luteal 
phase, making it more likely for these women to consolidate the traumatic memories. 
However, because ALLO stimulating GABA would typically be protective against 
flashbacks and anxiety, a problem in the conversion of progesterone to ALLO could lead 
to reduced GABAA functioning and lower inhibition in the central nervous system, 
allowing for greater physiologic reactivity in response to traumatic or startling stimuli 
during the luteal phase (Uzunova, Ceci, Kohler, Uzunov, & Wrynn, 2003; Rasmusson et 
al., 2006; Nillni, Toufexis, & Rohan, 2011). 
NEUROBIOLOGY AND MODELS OF ANXIETY 
 
There are several structures in the central nervous system involved in fear and 
anxiety regulation. The amygdala and the hippocampus are particularly important, as well 
as the bed nucleus of the stria terminalis (BNST), a structure running along the margin of 
the thalamus, and the central nucleus of the amygdala (CeA). Among other functions the 
BNST acts as a relay site for the hypothalamic-pituitary-adrenal axis (HPA axis) (Choi, 
Furay, Evanson, Ostrander, Ulrich-Lai, & Herman, 2007). It is also sexually dimorphic, 
twice as large in men as in women (Swaab, 2007). The CeA is the major output nucleus 
of the amygdala. It is largely responsible for the autonomic aspects of emotions by 
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connecting with the lateral hypothalamus and the brainstem (Kalin, Shelton, & Davidson, 
2004; Keifer, Jr., Hurt, Ressler, & Marvar, 2015). 
Makino et al. (1999) recorded corticotropin-releasing hormone (CRH) mRNA 
levels in the hypothalamus and the amygdala following psychological stress in rats. 
While there wasn’t a clear result of which structure was more sensitive, the study found 
increased levels of CRH mRNA in the CeA and the dorsolateral BNST. Lee and Davis 
(1997) also looked at the role of the BNST and CeA in anxiety regulation through CRH 
release after stress, this time using acoustic startle, by injecting CRH 
intracerebroventricularly. They found the BNST reacted most strongly to the 
intracerebroventricular CRH, suggesting the BNST is the primary location of receptors 
involved in the acoustic startle reflex (ASR). 
Stress Response. The sympathetic nervous system is pivotal in launching a stress 
response. The term “fight or flight” exemplifies how the sympathetic nervous system 
responds to stress: heart rate increases, peripheral blood flow increases so muscles can be 
more oxygenated, sweat glands are activated, pupils dilate, and renin is secreted in the 
kidneys. Stressors stimulate the paraventricular nucleus (PVN) of the hypothalamus to 
secrete CRH (a peptide hormone and a neurotransmitter), which travels through the 
hypothalamo-hypophyseal portal system to the anterior pituitary gland. There CRH binds 
to receptors on corticotropes and stimulates the production of adrenocorticotropic 
hormone (ACTH) and β-endorphins. ACTH is secreted in the blood and acts on the 
adrenal glands, stimulating production of cortisol, glucocorticoids, and DHEA as well as 
mineralocorticoids. Cortisol subsequently stimulates gluconeogenesis and acts as a 
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diuretic. These and other actions collectively increase glucose, potassium, and sodium 
concentrations in the system. Cortisol contributes to fight or flight by mobilizing fatty 
acids, glucose, and amino acids so they are available to create a boost of energy. Cortisol 
also suppresses the immune system and increases blood pressure. Catecholamines like 
norephinephrine and epinephrine bind to receptors at a number of sites, leading to 
accelerated heart rate and other aforementioned components of the stress response. 
The BNST also has a high concentration of CRH-containing cell bodies, 
projecting into several parts of the brainstem including the parabrachial nuclei. CRH 
perikarya at the CeA send terminals to the parabrachial nuclei and the BNST, both of 
which then send projections to the parvocellular region of the PVN. Thus CRH may 
influence neuroendocrine and autonomic functioning: a signal registering at the amygdala 
could stimulate CRH production at the PVN and subsequently the HPA axis through 
these neural connections (Arborelius, Owens, Plotsky, & Nemeroff, 1999). 
Depression and anxiety disorders have been linked to malfunctioning in the HPA 
axis. Individuals with depression may have a hyperreactive HPA axis (Plotsky, Owens, & 
Nemeroff, 1995). The hypercortisolemia due to a hyperreactive HPA axis is considered a 
state quality of depression rather than a trait such that it is related to a particular phase of 
the illness rather than consistently present (Gillespie & Nemeroff, 2005); while 
counterintuitive when considering fight or flight, it may lead to compensatory effects like 
a blunted ACTH response to high levels of CRH or a downregulation of pituitary CRH 
receptors secondary to increased hypothalamic CRH. For example, fewer CRH receptors 
were found in the prefrontal cortex (PFC) of suicide victims, suggesting a compensatory 
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adaptation to chronically high CRH in this region (Arborelius et al., 1999). ALLO has 
been shown to have anxiolytic- and antidepressant-like effects. Uzunova et al. (2003) 
showed decreased ALLO levels in the cerebrospinal fluid of individuals with major 
depressive disorder, which has been shown to increase with successful antidepressant 
therapy and reversal of psychopathology. In this study, olfactory bulbectomized rats were 
used to model depression experimentally; following surgery the rats’ ALLO levels 
dropped drastically in the amygdala and frontal cortex. As ALLO is a strong positive 
endogenous allosteric modulator of the GABAA receptor, this indicates reduced ALLO in 
depressive individuals may contribute to reduced GABAA activation and GABAergic 
tone in the amygdala and frontal cortex (Uzunova, Ceci, Kohler, Uzunov, & Wrynn, 
2003). 
The anxiogenic effects of CRH have been hypothesized to be in part regulated by 
CRH acting on the noradrenergic systems of the locus coeruleus (LC) (Arborelius et al., 
1999). At the LC, there are synaptic connections between CRH-containing terminals 
from the CeA and dendrites or noradrenergic neurons in the LC. CRH released here at the 
LC causes NE to be released, causing a stress-induced anxiety and aversion response. 
Increases in LC-NE activity are anxiogenic (Yajie, Hunt, & Sah, 2015). With repeated 
stress, tyrosine hydroxylase, the rate limiting enzyme in NE synthesis, is elevated; since 
this can be blocked by a certain CRH antagonist, it appears the process is at least partly 
dependent on CRH (Arborelius et al., 1999). Rajbhandari, Baldo, and Bakshi (2015) 
demonstrated that rodents exposed to repeated stress developed long-lasting sensitization 
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of basolateral nucleus of the amygdala (BLA) norepinephrine α1 receptors though a 
CRH-dependent mechanism, manifesting as heightened startle. 
In individuals with PTSD, there is a difference in the way the HPA axis 
malfunctions: there are higher CRH concentrations in cerebrospinal fluid (CSF) and there 
is a blunted ACTH response to high CRH, but they show hypocortisolism, unlike in 
patients with other anxiety disorders (Arborelius et al., 1999). This suggests a difference 
in the HPA axis where cortisol is produced at the adrenal gland. 
 
 
Figure 3: The hypothalamic-pituitary-adrenal axis. Hyman, (2009). 
 
Glucocorticoids are released from the zona fasciculata of the adrenal cortex in 
response to ACTH. Glucocorticoids, including cortisol, stimulate gluconeogenesis and 
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play a role in memory consolidation. They interact with the hypothalamic-pituitary- 
gonadal axis at a number of levels – indirectly at the brain, directly at the gonads. The 
ways glucocorticoids influence functioning at these organs depend on the presence of 
glucocorticoid receptors. At basal HPA axis levels, glucocorticoids can inhibit GnRH and 
progesterone acts to protect GnRH (Calogero et al., 1999). Stress-induced HPA activity 
causes a rise in glucocorticoid release, which dampens the HPA axis through negative 
feedback (see Figure 3) and inhibits GnRH. Subsequently FSH and LH levels drop. 
However glucocorticoids have a synergistic effect on FHS-stimulated progesterone: 
glucocorticoids enhance progesterone production and inhibit progesterone metabolism by 
stimulating 3β-hydroxysteroid dehydrogenase (3β-HSD), which converts pregnenolone to 
progesterone, and inhibiting 20α-HSD, which metabolizes progesterone to cofactors and 
a progesterone-like derivative (Whirledge & Cidlowski, 2010). Thus, with more 
progesterone, more ALLO ought to be made, and ultimately more GABA as well due to 
increased allosteric modulation via ALLO at GABAA receptors. A deficiency in ALLO 
due to a malfunctioning enzyme in the progesterone metabolism pathway is one potential 
mechanism underlying PTSD symptoms (Rasmusson et al., 2006). 
FEAR CONDITIONING 
 
Beyond the hormonal and physiologic aspects, behavior plays a significant role in 
PTSD. One theoretical model of PTSD is based on learning theory. According to learning 
theory models, specific stimuli, innocuous or otherwise, present during the event become 
associated a traumatic event such that when those stimuli are encountered after the event 
the feelings associated with the trauma are reawakened. These associations can be 
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changed via extinction learning over time: with every new exposure to the stimuli in the 
absence of a trauma a new association in which the lack of threat is learned. However, 
some individuals have difficulty with extinction learning or retention of extinction 
learning. These individuals may be those who develop and maintain PTSD. One of the 
primary features of PTSD and other similar conditions (panic disorder, agoraphobia) is 
avoidance behaviors. These behaviors are designed to protect the individual from the 
possibility of harm and the feared outcome. In doing so, patients are prevented from 
“challenging unrealistic beliefs and thus prevent fear extinction” (Milad, Rosenbaum, & 
Simon, 2014). The original conditioned fear associations remain, continuing to cause 
intense stress and other adverse effects both on mental and physical health. 
Fear conditioning laboratory tasks demonstrate how an organism can learn to fear 
a previously neutral stimulus by undergoing several trials in which it is paired with 
aversive stimuli. For example, a soldier may come to associate loud explosions with a 
contextual threat of potential death and the trauma they experienced when at war such 
that they have an aversive reaction to fireworks on the Fourth of July. Generally there are 
three phases in laboratory-based fear conditioning paradigms: habituation (the 
conditioned stimulus (CS) is presented until the participant habituates and the response 
normalizes), acquisition (in which the aversive stimulus (UCS) is presented with the CS 
and the conditioned stimulus-conditioned response (CS-CR) relationship is established 
and learned), and extinction (in which the association made at acquisition is no longer 
present such that the conditioned response (CR) does not occur after repeated 
presentation of the conditioned stimulus (CS) without the UCS). 
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The first study of fear conditioning in individuals with PTSD was conducted by 
Orr et al. (2000). The authors looked at the association between conditionability and 
PTSD status. This study was based on the theory that some PTSD symptoms are seen as 
conditioned responses to a traumatic UCS, and some people who are more prone to 
acquire conditioned responses in the first place are more likely to develop such 
symptoms. Conditionability may then present practically and experimentally as slower 
extinction of the CR. Orr et al. (2000) found evidence that an aversively conditioned 
electrodermal response to a previously neutral stimulus was acquired more strongly in 
individuals with PTSD; these individuals were also more resistant to extinction. It is not 
clear however what the origin of this conditionability is: if it is a pre-trauma trait it would 
serve as a valuable vulnerability marker (Orr et al., 2000). 
The amygdala, hippocampus, and PFC are all implicated in both fear conditioning 
and PTSD. The amygdala regulates learned fear and receives projections from the 
hippocampus and PFC; it is directly involved in emotion reaction regulation. Individuals 
with PTSD show reduced overall activation of the PFC and hippocampus, and thus 
reduced activation of the amygdala. This may coincide with reduced top-down control of 
the amygdala, possibly resulting in a hyper-responsive amygdala signal to fearful stimuli. 
Disordered fear regulation in PTSD and other similar disorders could be explained by this 
malfunction (Mahan & Ressler, 2012). 
Activation of the amygdala has been shown to be positively correlated with PTSD 
symptom severity and self-reported anxiety. There is also a relationship between the 
amygdala and the medial prefrontal cortex (mPFC). The PFC often plays the role of 
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rationality and toning down the animal instincts of the amygdala. In individuals with 
PTSD, there is a reciprocal relationship between the mPFC and the amygdala: as regional 
cerebral blood flow at the medial frontal gyrus of the mPFC decreases, regional cerebral 
blood flow at the amygdala increases. Additionally, in individuals with PTSD the 
hippocampus, directly involved in encoding context during fear conditioning, usually has 
decreased volume (Shin, Rauch, & Pitman, 2006). Fear conditioning results in reduced 
GABAergic signaling in the BLA compared to non-fear conditioned controls (Mahan & 
Ressler, 2012). 
These areas of the brain involved in fear conditioning are both sexually dimorphic 
and contain estrogen receptors, suggesting multiple means for sex differences in PTSD 
manifesting in reproductive-age women compared to men. Milad et al. (2006) studied sex 
differences in fear conditioning of healthy individuals upon observing anxiety disorders 
being much more prevalent in women than men and women’s failure to extinguish 
conditioned fear in existing literature. The study looked at women in the eFP (low 
estrogen and progesterone), women in the late follicular phase (high estrogen, low 
progesterone), and men; results showed less extinction memory in healthy women in the 
late follicular phase compared to women in the eFP and men. In terms of neurobiology, 
the authors hypothesized late follicular phase women would display less extinction 
retention because the vmPFC, which is involved in fear conditioning and extinction 
retention, exhibits less responsivity during this phase. However estrogen has been shown 
to enhance synaptogenesis, long term potentiation, and learning and memory in a variety 
of hippocampal-dependent paradigms in healthy women. The authors concluded that high 
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estrogen at mid-cycle increases contextual generalization, which could lead to increased 
conditioned fear responding in the extinction context. 
Milad et al. (2010) delved deeper into the matter of estradiol’s potential protective 
effects and found estradiol levels did not affect acquisition or extinction of conditioned 
fear, only facilitated extinction recall in women. However some differences emerge once 
studies were directed at individuals with PTSD as opposed to healthy individuals. Glover 
et al. (2012) examined if women with PTSD at low estrogen levels would show deficits 
in fear inhibition compared to women with high estrogen levels; this study confirmed 
gonadal hormonal status influences fear inhibition. Lebron-Milad, Graham, and Milad 
(2012) built on Glover et al.’s (2012) findings and sought to determine if estrogen levels 
influence fear extinction in women with PTSD. The study ultimately found women with 
PTSD and low estradiol have much higher conditioned responses during extinction and 
greater symptom severity compared to trauma exposed women without PTSD at high or 
low estrogen and women with PTSD at high estrogen, implying low estrogen might be a 
vulnerability factor for developing PTSD in women with trauma histories. Just as 
symptom severity may diminish during the high estradiol phases so may the 
vulnerability; conversely the low estradiol sections of the menstrual phase – namely, the 
mLP – may be the most vulnerable windows for developing PTSD and other anxiety 
disorders. While there is a strong case for estradiol playing a central role in anxiety 
disorders, it does not function alone and thus affects a number of other hormones, 
including progesterone and its metabolites and CRH. 
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Pineles et al. (in press) studied female trauma survivors with and without PTSD 
by testing them with a differential fear conditioning task in either the eFP or mLP. Skin 
conductance was measured to operationalize conditioned fear. Results showed a 
difference in extinction retention patterns at eFP and mLP in women with PTSD 
compared to women without PTSD. Extinction retention was better in the mLP (high 
estradiol, high progesterone) for women without PTSD. However, women with PTSD 
showed poorer extinction retention in the mLP; in this group high progesterone was also 
associated with poorer extinction retention. These findings underline the possibility that 
estrogen (and progesterone) plays a protective role in healthy women but creates a 
window of vulnerability in women with PTSD. 
LOUD TONES TASK 
 
One of the symptoms of PTSD is exaggerated auditory startle reflex (ASR), 
considered a result of hyperarousal. Orr, Lasko, Shalev, and Pitman (1995) found 
increased orbicularis oculi muscle startle response in Vietnam War veterans with PTSD 
when exposed to 15 loud tones, and the authors suggested the role of anxiety in this 
exaggerated startle. The loud tones paradigm used was based on the procedure used by 
Shalev et al. (1992): fifteen pure tones were generated and presented via headphones 
worn by the participants while they were hooked up to systems used to measure left 
orbicularis oculi electromyogram (EMG), skin conductance (SC), and heart rate (HR), 
which together were used to operationalize ASR. This procedure, which is used in the 
current study, is detailed in the Methods section of this paper. 
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Shalev, Peri, Orr, Bonn, and Pitman (1997), using the paradigm in Shalev et al. 
 
1992, studied medication-free help-seeking trauma survivors with PTSD, male and 
female, and found those with PTSD to have overall higher average EMG, SC, and HR 
responses, indicating overall greater arousal. The study found heightened autonomic 
response reactivity to loud tones and an increased EMG response. Higher auditory startle 
reflex (ASR) responses were found to be associated with current PTSD diagnosis rather 
than trauma exposure. Morgan, Grillon, Lubin, and Southwick (1997) tested the “shock 
sensitization of startle” model of exaggerated startle in women with sexual assault-related 
PTSD following a different experimental paradigm: two pulse-alone trials and a prepulse 
plus pulse trial. The study found significant differences for left O-EMG responses, 
suggesting a laterality effect supported by findings of left-sided hippocampal 
abnormalities in civilian women with PTSD. 
Metzger et al. (1999) tested if exaggerated startle in women represents trauma- 
induced sensitization that dissipates over time even if PTSD symptoms persist, which 
would suggest that ASR is more likely to occur in recent rather than chronic or lifetime 
PTSD. The study found women with current PTSD had significantly larger HR responses 
and slower SC habituation rates, though no difference was found in EMG responses. The 
authors thus found that the exaggerated startle reactivity persists even in spite of 
diminished PTSD symptomatology. 
SUMMARY AND AIMS OF CURRENT STUDY 
 
There is emerging evidence that PTSD in women may be influenced by the 
menstrual cycle and its associated fluctuating hormone levels. The mid-luteal phase may 
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be a window of vulnerability for development and maintenance of PTSD. A number of 
neurobiological structures and pathways are involved in the mechanisms that could 
influence PTSD symptom presentation; research points toward malfunctioning HPA axis 
responses to prolonged stress and other abnormalities such as deficiencies in ALLO due 
to malfunctioning enzymes in progesterone metabolism. Inherent to some of these 
structures is sexual dimorphism and the presence of estrogen receptors that may 
predispose women to the demonstrated higher vulnerability to development of anxiety 
disorders. Fear conditioning studies have shown stronger acquisition of aversively 
conditioned responses to neutral stimuli and greater resistance to extinction in individuals 
with PTSD. Women with PTSD showed significantly larger HR responses and slower SC 
habituation to a loud tones task compared to trauma control healthy participants (Metzger 
et al, 1999) and significant differences in left orbicularis EMGR compared to controls 
(Morgan, Grillon, Lubin, & Southwick, 1997). 
The current study investigated if the phase of the menstrual cycle affects 
performance on the loud tones task in women with PTSD. The following were the 
hypotheses for this study: 
1. Women with PTSD will display greater reactivity (higher EMGR, 
HRR, and SCR) in response to the loud tones task than women in the trauma- 
exposed control group. 
2. Menstrual phase (eFP or mLP) will moderate the relationship 
between PTSD and performance on the loud tones task such that the difference in 
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reactivity (i.e., (higher EMGR, HRR, and SCR) between women with and 
without PTSD will be greater in the mLP as compared to the eFP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Hypothesized relationship between PTSD and increased reactivity, moderated 
by menstrual cycle phase. 
SPECIFIC AIMS 
 
The literature supports the sex differences in the way PTSD manifests in women 
and that the menstrual cycle hormones interact with the compounds and brain structures 
involved with PTSD. The specific aims of this study are: 
1. To determine if PTSD in women promotes reactivity to the loud 
tones task, as previous studies have shown 
2. To determine if this reactivity varies depending on the phase of the 
menstrual cycle during testing 
Menstrual 
Cycle 
Phase 
 
PTSD 
 
Increased 
Reactivity 
21  
 
 
Determining if the menstrual cycle contributes to the blatant sex differences in 
how frequently trauma-exposed women develop PTSD and for how long the symptoms 
last would be a valuable insight that could contribute to the way these women are treated 
for their PTSD. Recovery from the trauma experienced is key for these women to be able 
to go through daily life without the hindrances imposed by PTSD. While this study does 
not look at the underlying neurobiological mechanisms directly, inferences can be drawn 
regarding which hormones and brain structures are involved, given the evidence for such 
connections in prior studies. 
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METHODS 
 
 
PARTICIPANTS 
 
Forty-six women who experienced a traumatic event participated in the current 
study. There were two groups of participants: women with PTSD (PTSD) (n = 22) and 
women exposed to trauma without PTSD (trauma control) (n = 24). Participants ranged 
in age from 19 to 49 years, M = 32.15; peri- and post-menopausal women were excluded. 
For inclusion in the PTSD group, participants needed to meet criteria for current 
PTSD. Participants in the trauma control group experienced a traumatic event but did not 
meet the criteria for lifetime or current PTSD or any current Axis I disorders with the 
exception of specific phobia. Additional exclusion criteria included current infectious 
illnesses, current or history of organic brain disorder, major neurological problems, 
endocrine disorders, schizophrenia, psychotic disorder, bipolar disorder, current active 
substance dependence, hearing impairment for 1000 Hz tones or white noise, irregular 
menstrual cycle, current participation in active-trauma focused psychotherapy, and use of 
psychotropic medications, oral contraceptives, or other medications with potential effects 
on the tasks or hormones being measured. Participants needed to be free of alcohol or 
illicit drugs for two weeks. 
SYMPTOMATIC ASSESSMENTS AND PSYCHOMETRICS 
 
Clinician-Administered PTSD Scale for DSM-IV (CAPS) (Blake, Weathers, 
Nagy, Kaloupek, Gusman, Charney, & Keane, 1995). The CAPS is a semi-structured 
interview conducted by a mental health professional to determine current PTSD 
diagnosis, lifetime PTSD diagnosis, and recent symptoms. The CAPS is the gold standard 
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for PTSD diagnosis. Patients are asked to keep up to three traumatic events in mind 
throughout the duration of the assessment. Participants are assessed for the possible 
presence of the 17 symptoms of PTSD. If a symptom is present, the interviewer queries 
the participant about the duration and severity of the symptom. After each symptom is 
assessed, the duration of symptoms, the participant’s subjective distress and how the 
PTSD symptoms impact functioning are examined. There are several versions of CAPS: 
past week, past month, and worst month (lifetime) (Blake, et al., 1995). For the current 
study, past month and lifetime were assessed. 
Symptom frequency and symptom intensity are rated on Likert-style scales with 
responses ranging from 0 to 4. Diagnostic scores can be determined following 9 different 
scoring rules from which the appropriate rules for the situation are selected. These rules 
were studied and detailed by Weathers, Ruscio, and Keane, 1999. A commonly used 
scoring rule for counting a symptom is 1 or more frequency symptoms and 2 or more 
intensity symptoms. A diagnosis is made if there is at least 1 B symptom, 3 C symptoms, 
and 2 D symptoms as well as meeting the other diagnostic criteria (“CAPS Instruction 
Manual”, 2015). In this study, participants who endorsed at least 1 B symptom, 3 C 
symptoms, and 2 D symptoms and achieved a CAPS score greater than 40 qualified for 
the PTSD group. The no PTSD group/trauma control had CAPS scores lower than 40 and 
did not meet criteria for lifetime, current, or past PTSD. 
Structured Clinical Interview for DSM-IV Axis 1 Disorders (SCID-1) (First, 
Spitzer, Gibbons, & Williams, 2002). SCID-1 is a diagnostic exam for major DSM-IV 
Axis 1 disorders. It is a widely used assessment in the form of a semi-structured 
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interview, performed by a mental health professional. There are several versions of 
SCID-1, including ones for clinical and research purposes (“SCID Frequently Asked 
Questions”, 2015). This study used the clinical version of SCID-1. The SCID was used in 
the current study to assess for inclusion exclusionary criteria and to characterize the 
sample with regard to comorbid diagnoses. 
State-Trait Anxiety Inventory (STAI) (Speilberger, Gorsuch, Lushene, Vagg, 
& Jacobs, 1983). STAI is an assessment of state and trait anxiety used in clinical 
settings. There are 20 items each for state and trait anxiety, the former indicating current 
feelings of anxiety and the latter indicating more chronic feelings. Items are graded on a 
four-point Likert scale. Higher scores indicate higher anxiety (The State-Trait Anxiety 
Inventory (STAI), n.d.). This study used STAI-Trait. 
PTSD Checklist (PCL) (Weathers, Litz, Herman, Huska, & Keane, 1993). 
 
The PCL is a 17-item self-report of DSM-IV PTSD symptoms used to characterize PTSD 
symptom severity. Responses are given on a 1-5 Likert-like scale. There are there 
versions of PCL: military, civilian, and specific (“Using the PTSD Checklist for DSM-IV 
(PCL)”, 2014). This study used the civilian version, PCL-C. 
Traumatic Life Events Checklist (TLEC) (Kubany, Leisen, Kaplan, Watson, 
Haynes, Owens, & Burns, 2000). The TLEC is a 17-item self-report questionnaire 
designed to screen for potentially traumatic life events by assessing exposure to 16 events 
that could potentially meet criteria for a trauma as defined by DSM-IV. Response options 
are the following: Happened to me, Witnessed it, Learned about it, Not Sure, and Doesn’t 
apply. There are three versions of TLEC: standard (to determine if a traumatic event was 
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experienced), extended (to establish the worst event if more than one occurred), and 
interview (to determine if Criterion A for PTSD is met) (“Life Events Checklist for DSM- 
5 (LEC-5)”, 2015). This study used the standard version of TLEC. 
Beck Depression Inventory (BDI) (Beck, Steer, & Brown, 1996). The BDI is a 
21-item self-report measuring characteristic attitudes and symptoms of depression, the 
most recent version being the BDI-II. Responses are made using a 0-3 Likert-like scale. 
Scores range from 0 to 63; higher scores indicate more severe depressive symptoms 
(Beck Depression Inventory (BDI), n.d.). 
Childhood Trauma Questionnaire (CTQ) (Bernstein, Fink, Handelsman, 
Foote, Lovejoy, Wenzel, Sapareto, & Ruggiero, 1994). The CTQ is a 28-item self- 
report questionnaire used to rate the severity of six types of traumatic childhood events: 
death, divorce, violence, sexual abuse, illness, or other. Responses are given using a 5 
point Likert scale. It can be administered to adolescents age 12 and over and to adults 
(Measurement Instrument Database for the Social Sciences, n.d.). 
PROCEDURES 
 
Session 1 and 2. After providing informed consent, participants’ height and 
weight were measured. Prior to testing, participants were asked to abstain from caffeine 
after 10am. Smokers were included in the study but were asked to abstain from cigarettes 
for one hour before coming in for the session. Participants were asked to provide a urine 
sample for a drug screen, cotinine levels to measure overall intensity of smoking, a 
pregnancy test indicated by urine human chorionic gonadotropin, and urinalysis. 
Participants were seated for 20 to 30 minutes during which a medical, psychiatric, and 
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substance abuse history was taken. Blood samples were also collected for routine 
laboratory tests and DNA testing. A hearing test and physical exam was conducted by a 
physician or physician’s assistant. All participants were assessed by the Structured 
Clinician Interview for DSM-IV Axis I Disorders (SCID-I) and the Clinician 
Administered PTSD Scale (CAPS). Other assessments included Beck Depression 
Inventory (BDI), Childhood Trauma Questionnaire (CTQ), Traumatic Life Events 
Checklist (TLEC), State-Trait Anxiety Inventory (STAI), and PTSD Checklist for 
Civilians (PCL-C). Participants completed the self-report-style psychometric 
assessments, including CTQ, TLEC, BDI, PCL-C, and STAI-Trait, and were interviewed 
for CAPS and SCID. 
Participants were assigned in a pseudorandom manner to the menstrual phase 
during which they would first be tested. Half of the women first completed the loud tones 
task during the mid-luteal phase (mLP) of the menstrual cycle while the other half 
completed the task during the early follicular phase (eFP) in the first session, and then 
again in the other phase in the second session. These phases were chosen specifically for 
displaying the highest degree of contrast in progesterone and estradiol levels (low levels 
at eFP and high levels at mLP). In total each participant was tested twice, once in each 
phase. 
Menstrual cycle monitoring and test scheduling. Testing during eFP was 
scheduled for two to six days after the start of menstruation, when progesterone and 
estrogen levels are low and stable. To schedule testing during mLP, a urine test kit was 
used to determine the day of the LH surge during the middle of the cycle, which occurs 
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about 24 hours prior to ovulation and the start of the luteal phase. Participants were 
instructed which days to use the kit and were reminded by phone to do so and to call 
when the LH surge occurred so the testing could be scheduled 6-10 days later, when 
estrogen and progesterone levels are highest and most stable. Phase was confirmed at the 
time of testing by measuring progesterone and estrogen levels. 
Sessions 3 and 5. At the time of testing an IV was inserted into the participant’s 
antecubital vein. After a 20 minute rest period, blood samples were collected; estradiol 
and progesterone levels were assayed to confirm menstrual phase. Participants then 
performed the loud tones task. 
Sessions 4 and 6. A task not included in the current study was administered to the 
participants in sessions 4 and 6. 
STIMULI 
 
Stimuli consisted of fifteen 95 dB, 1000 Hz tones presented for 500ms with less 
than 1ms rise and fall times. Duration of intertrial intervals was randomly selected by a 
computer, ranging from 27 to 52 seconds. 
Procedure. Participants were seated upright in a sound attenuated room 
connected to an experimental control room by wires. Once electrodes were applied to the 
participant, they were instructed they would have 5 minutes of relaxation time and would 
be followed by the loud tones task. Headphones were placed on the participant. At the 
conclusion of the relaxation time, the participant heard a series of loud tones, controlled 
by the technician in the control room. Data regarding physiologic measures was collected 
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beginning 4 seconds prior to presentation of a tone at 1000 Hz and stopped 8.5 seconds 
after the tone. 
PHYSIOLOGIC MEASURES 
 
During the loud tones task, several physiologic measures were used to 
operationalize physiological reactivity: left orbicularis oculi electromyogram (O-EMG), 
skin conductance (SC), and heart rate (HR). O-EMG was measured by 4-mm Beckman- 
type Ag/AgCl surface electrodes filled with electrolyte paste to be placed over the left 
orbicularis oculi muscle. HR was measured by standard limb electrocardiogram leads. O- 
EMG and HR were amplified and filtered by the Coulbourn Isolated Bioamplifier with 
filter parameters set at 90-1000 Hz and 10ms integration time constant. SC response was 
measured directly by a Coulbourn Isolated Skin conductance coupler. 
RESPONSE DEFINITIONS 
 
O-EMG response scores (O-EMGR) were calculated for each trial by subtracting 
the mean O-EMG level during the 100ms immediately prior to tone onset from the 
highest O-EMG level within 20-120 milliseconds following the tone. The mean of the 
fifteen O-EMGRs was calculated for each of the participants, and then treated by a 
square-root transformation. A more positive O-EMGR indicates greater startle reactivity 
to the tones. HR response score (HRR) and SC response score (SCR) were calculated 
similarly within 1 second prior and 1-4 seconds after the tone. Mean HRR and SCR were 
calculated for each participant. More positive HRR and SCR scores indicate greater HR 
and SC reactivity. HR means, SC means, and EMG means were used in the analyses. 
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Additionally, the rate of habituation across the 15 trials was calculated and 
operationalized as the slope for HR, SC, and EMG. Finally, for SC and EMG, a value 
was specified for each measure as the point at which habituation was reached (two trials 
in a row with a response greater than or equal to 0.05 for SC, two trials in a row with a 
response greater than or equal to 0.6 for EMG) and the number of trials to this 
habituation marker was recorded. 
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RESULTS 
 
 
 
Data Analyses 
 
A series of 2 (PTSD: PTSD or no PTSD) x 2 (Menstrual Phase: eFP or mLP) x 2 
(Order: eFP or mLP first) repeated-measures ANOVAs were conducted on means and 
habituation rates of skin conductance (SC), heart rate (HR), and left orbicularis 
electromyogram (EMG) as well as time to habituation for SC and EMG for a total of 
eight RM-ANOVAs. 
Demographics 
 
The majority of participants was non-Hispanic African American women with 
some college education and unemployed without being enrolled in school. Most 
participants were never married and non-smokers. There were no significant differences 
between the PTSD and trauma control groups on the demographic variables (see Table 
1). 
There were significant differences between the PTSD group and the trauma 
control group for all of the psychologic assessment measures (p < 0.001) (see Table 2). 
Specifically, the PTSD group scored higher on measures of PTSD symptom severity (as 
measured by the CAPS), depressive symptoms (as measured with the BDI), and trait 
anxiety (as measured with the STAI-Trait). 
The SCID-I was used to assess the presence of current axis 1 disorders (see Table 
3). More individuals within the PTSD group qualified for an anxiety or mood disorder as 
compared to the trauma control group. 
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Table 1. Participant Demographics  
 Total  PTSD  Trauma 
     
Control
 
Variable n % n % n % χ
2 
p
Ethnicity 
     
2.281 
Hispanic 2 4.3 2 9.1 0 0.0 
Non-Hispanic 44 95.7 20 90.9 24 100.0 
Race 
      
5.199 
Caucasian 15 32.6 5 25.0 10 41.7 
  
African American 19 41.3 9 45.0 10 41.7 
  
Asian American 5 10.9 4 20.0 1 4.2 
  
American Indian 1 2.2 1 5.0 0 0.0 
  
Other 4 8.7 1 5.0 3 12.5 
  
Years of Education 
      
11.753 
< High School 1 2.2 1 4.5 0 0.0 
  
High School/GED 6 13.0 6 27.3 0 0.0 
  
Some College 20 43.5 8 36.4 12 50.0 
  
2 Year Degree 2 4.3 0 0.0 2 8.3 
  
4 Year Degree 11 23.9 4 18.2 7 29.2 
  
Some Graduate School 5 10.9 2 9.1 3 12.5 
  
Graduate School complete 1 2.2 1 4.5 0 0.0 
  
Employment 
 
Full-Time Work 
 
 
6 
 
 
13.0 
 
 
2 
 
 
9.1 
 
 
4 
 
 
16.7 
8.792 
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Part-Time Work 9 19.6 3 13.6 6 25.0  
Full-Time School 6 13.0 1 4.5 5 20.8 
 
Part-Time School 2 4.3 2 9.1 0 0.0 
 
Unemployed, No School 17 37.0 10 45.5 7 29.2 
 
Part-Time Work, Full-Time School 4 8.7 2 9.1 2 8.3 
 
Part-Time Work, Part-Time School 1 2.2 1 4.5 0 0.0 
 
Full-Time Work, Full-Time School 1 2.2 1 4.5 0 0.0 
 
Marital Status 
     
3.453 
Married/Cohabiting 5 10.9 3 13.6 2 8.3 
 
Widowed 1 2.2 1 4.5 0 0.0 
 
Divorced 3 6.5 2 9.1 1 4.2 
 
Separated 1 2.2 1 4.5 0 0.0 
 
Never Married 36 78.3 15 41.7 21 58.3 
 
Current Smoker 
     
0.057 
Yes 10 21.7 5 23.8 5 20.8 
 
No 35 76.1 16 76.2 19 79.2 
 
 
 
Table 2. Symptom and Psychologic Assessments 
 
 Total  PTSD  Trauma Control   
Assessment M SD M SD M SD t p 
PTSD Scale (CAPS) 36.457 32.798 67.046 19.107 8.417 7.447 7.539 <0.001 
PTSD Checklist (PCL- 
 
C) 
40.902 18.132 55.750 12.340 27.292 10.002 15.299 <0.001 
Trait Anxiety (STAI - 45.154 14.167 56.061 9.708 35.156 9.411 21.617 <0.001 
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Trait)         
Depression (BDI) 14.501 11.987 24.441 8.683 5.390 5.583 8.205 <0.001 
Traumatic Life Events 
 
(TLEC) 
11.818 10.026 15.905 11.861 8.087 6.171 7.819 <0.001 
Childhood Trauma 
(CTQ) 
48.064 23.219 57.685 28.105 39.646 13.641 13.886 <0.001 
 
 
 
Table 3. Current Axis 1 Disorders 
 
 
Total PTSD Trauma 
Control 
n % n % n % χ
2 
p 
 
Anxiety 18.473 <0.001 
 
Yes 15 32.6 14 63.6 1 4.2  
No 31 67.4 8 36.4 23 95.8 
Mood 
 
Yes 
 
 
10 
 
 
21.7 
 
 
10 
 
 
45.5 
 
 
0 
 
 
0 
13.939 <0.001 
No 36 78.3 12 54.5 24 100 
  
Binge Eating 
      
2.281 0.131 
Yes 2 95.7 2 9.1 0 0 
  
No 
 
Body Dysmorphic 
44 4.3 20 90.1 24 100 
 
 
2.281 
 
 
0.131 
Yes 2 95.7 2 9.1 0 0 
  
No 44 4.3 20 90.1 24 100 
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ANOVA Results 
 
Bolded lines indicate statistically significant effects (p<0.05). Italicized lines indicate trends 
(p<0.1). 
 
Heart Rate. 
 
Mean. There was a significant main effect of Menstrual Phase, F(1,35) = 5.851, p 
 
= 0.021 (see Table 4). Participants in the eFP exhibited lower mean heart rates, M = 
 
1.375 s
-1
, SD = 0.154, than participants in the mLP, M = 1.793, SD = 0.149. 
 
Table 4. Mean Heart Rate 
 
 
Source df SS MS F p Partial 
 
η2 
Menstrual Phase 1,35 2.481 2.481 5.851 0.021 0.143 
PTSD 1,35 0.053 0.053 0.042 0.840 0.001 
Order 1,35 1.057 1.057 0.821 0.371 0.023 
Menstrual Phase x PTSD 1,35 0.046 0.046 0.108 0.745 0.003 
Menstrual Phase x Order 1,35 1.654 1.654 3.900 0.056 0.100 
PTSD x Order 1,35 3.760 3.760 2.921 0.096 0.077 
Menstrual Phase x PTSD x 
Order 
1,35 0.161 0.161 0.379 0.542 0.011 
 
 
Slope (Rate of Habituation). There were no significant main effects or 
interactions of the rate of habituation of heart rate (see Table 5). 
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Table 5. Heart Rate Slope 
 
 
Source df SS MS F p Partial 
 
η2 
Menstrual Phase 1,35 9.519E- 
 
5 
9.519E- 
 
5 
0.001 0.977 0.000 
PTSD 1,35 0.044 0.044 0.475 0.495 0.013 
Order 1,35 0.050 0.050 0.549 0.464 0.015 
Menstrual Phase x PTSD 1,35 0.064 0.064 0.572 0.455 0.016 
Menstrual Phase x Order 1,35 0.176 0.176 1.579 0.217 0.043 
PTSD x Order 1,35 0.032 0.032 0.352 0.557 0.010 
Menstrual Phase x PTSD x 
Order 
1,35 0.122 0.122 1.094 0.303 0.030 
 
 
Skin Conductance. 
 
Mean. Although not statistically significant, it is notable that the main effect of 
Menstrual Phase approached statistical significance, F(1,23) = 3.693, p = 0.067 (see 
Table 6). Importantly, the pattern of results was opposite to that of heart rate. Specifically 
participants in the eFP exhibited higher mean skin conductance response, M = 0.333, SD 
= 0.850, than participants in the mLP, M = 0.223, SD = 0.053. 
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Table 6. Mean Skin Conductance 
 
 
Source df SS MS F p Partial 
 
η2 
Menstrual Phase 1,23 0.156 0.156 3.693 0.067 0.138 
PTSD 1,23 0.079 0.079 0.356 0.557 0.015 
Order 1,23 0.021 0.021 0.094 0.762 0.004 
Menstrual Phase x PTSD 1,23 0.032 0.032 0.761 0.392 0.032 
Menstrual Phase x Order 1,23 0.052 0.052 1.232 0.279 0.051 
PTSD x Order 1,23 0.016 0.016 0.073 0.789 0.003 
Menstrual Phase x PTSD x 
Order 
1,23 0.039 0.039 0.929 0.345 0.039 
 
 
Slope (Rate to Habituation). There were no statistically significant main effects 
or interactions (see Table 7). 
Table 7. Skin Conductance Slope 
 
 
 
 
Source 
df SS MS F p Partial 
 
η2 
Menstrual Phase 1,23 0.079 0.079 0.871 0.360 0.036 
PTSD 1,23 0.342 0.342 1.141 0.297 0.047 
Order 1,23 0.047 0.047 0.156 0.697 0.007 
Menstrual Phase x PTSD 1,23 0.000 0.000 0.002 0.964 0.000 
Menstrual Phase x Order 1,23 0.312 0.312 3.448 0.076 0.130 
PTSD x Order 1,23 0.033 0.033 0.109 0.744 0.005 
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Menstrual Phase x PTSD x 
Order 
1,23 0.012 0.012 0.138 0.714 0.006 
 
 
Trials to Habituation. There was a significant interaction of Menstrual Phase and 
Order, F(1,23) = 5.335, p = 0.030 (see Table 8). Participants who were first tested in the 
follicular phase at session 3 took more trials on average to reach habituation in the 
follicular phase, M = 6.143, SD = 1.306, compared to the luteal phase in session 5, M = 
3.857, SD = 1.196. Participants who were first tested in the luteal phase in session 3 took 
more trials on average to reach habituation in the luteal phase, M = 5.300, SD = 1.276, 
than in the follicular phase in session 5, M = 3.787, SD = 1.393. 
Table 8. Skin Conductance Trials to Habituation 
 
 
Source df SS MS F p Partial 
 
η2 
Menstrual Phase 1,23 1.958 1.958 0.221 0.643 0.010 
PTSD 1,23 11.273 11.273 0.332 0.576 0.014 
Order 1,23 2.727 2.727 0.078 0.783 0.003 
Menstrual Phase x PTSD 1,23 7.777 7.777 0.878 0.358 0.037 
Menstrual Phase x Order 1,23 47.244 47.244 5.335 0.030 0.188 
PTSD x Order 1,23 19.343 19.343 0.552 0.465 0.032 
Menstrual Phase x PTSD x 
Order 
1,23 1.532 1.532 0.173 0.681 0.007 
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Left Orbicularis Electromyogram. 
 
Mean. There was a significant main effect of PTSD, F(1,31) = 5.264, p = 0.029 
(see Table 9). Counter to our hypotheses, participants with PTSD demonstrated lower 
mean EMGR, M = 3.046, SD = 0.511, than participants without PTSD, M = 4.624, SD = 
0.460. 
There was also a significant interaction of Menstrual Phase by Order, F(1,31) = 
6.034, p = 0.020 (see Table 6). Participants who were first tested in the follicular phase at 
session 3 had higher mean EMGR in the follicular phase, M = 4.167, SD = 0.439, 
compared to in the luteal phase at session 5, M = 3.786, SD = 0.518. Participants who 
were first tested in the luteal phase at session 3 had higher mean EMGR in the luteal 
phase, M = 4.314, SD = 0.640, than in the follicular phase at session 5, M = 3.073, SD = 
0.542. 
Table 9. Mean EMG Response 
 
 
Source df SS MS F p Partial 
 
η2 
Menstrual Phase 1,31 3.067 3.067 1.696 0.202 0.052 
PTSD 1,31 41.257 41.257 5.264 0.029 0.145 
Order 1,31 1.331 1.331 0.170 0.683 0.005 
Menstrual Phase x PTSD 1,31 5.155 5.155 2.850 0.101 0.084 
Menstrual Phase x Order 1,31 10.913 10.913 6.034 0.020 0.163 
PTSD x Order 1,31 16.712 16.712 2.132 0.154 0.064 
Menstrual Phase x PTSD x 1,31 2.293 2.293 1.268 0.269 0.039 
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Order 
 
 
 
Slope (Rate to Habituation). There were no significant main effects or 
interactions for EMG rate of habituation (see Table 10). 
Table 10. EMG Slope 
 
 
Source df SS MS F p Partial 
 
η2 
Menstrual Phase 1,31 0.000 0.000 0.002 0.966 0.000 
PTSD 1,31 0.165 0.165 1.119 0.298 0.035 
Order 1,31 0.026 0.026 0.175 0.679 0.006 
Menstrual Phase x PTSD 1,31 0.007 0.007 0.065 0.800 0.002 
Menstrual Phase x Order 1,31 0.083 0.083 0.773 0.386 0.024 
PTSD x Order 1,31 0.053 0.053 0.360 0.553 0.011 
Menstrual Phase x PTSD x 
Order 
1,31 0.177 0.177 1.651 0.208 0.051 
 
 
Trials to Habituation. There was a significant main effect of PTSD, F(1,31) 
 
=4.299, p = 0.047 (see Table 11). Participants with PTSD, M = 10.783, SD = 0.924, 
reached habituation in fewer trials than participants without PTSD, M = 13.361, SD = 
0.832. 
There was also an interaction of Menstrual Phase by PTSD that approached 
statistical significance, F(1,31) = 4.135, p = 0.05 (see Table 8). Participants without 
PTSD took more time on average to reach habituation in the follicular phase, M = 13.750, 
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SD = 0.940, compared to in the luteal phase, M = 12.972, SD = 0.963. Participants with 
PTSD took more time on average to reach habituation in the luteal phase, M = 11.800, SD 
= 1.071, compared to in the follicular phase, M = 9.767, SD = 1.044. 
 
Table 11. EMG Trials to Habituation 
 
 
Source df SS MS F p Partial 
 
η2 
Menstrual Phase 1,31 6.527 6.527 0.824 0.371 0.026 
PTSD 1,31 110.131 110.131 4.299 0.047 0122 
Order 1,31 11.559 11.559 0.451 0.507 0.014 
Menstrual Phase x PTSD 1,31 32.765 32.765 4.135 0.051 0.118 
Menstrual Phase x Order 1,31 0.006 0.006 0.001 0.979 0.000 
PTSD x Order 1,31 14.388 14.388 0.562 0.459 0.018 
Menstrual Phase x PTSD x 
Order 
1,31 2.458 2.458 0.310 0.582 0.010 
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DISCUSSION 
 
 
The current study examined the relationship between PTSD in women, the 
menstrual cycle and its associated hormones, and performance on the loud tones task (see 
Table 12 for summary figure). Some of the findings of the current study support the 
literature such that HRR scores were higher in the mLP, indicating higher reactivity. This 
was not the case for SCR and EMGR. Several of the major findings were in fact 
surprising: participants with PTSD demonstrated lower mean EMGR scores and reached 
habituation in fewer trials than participants without PTSD, contrary to our expectations. 
Additionally, the pattern of SCR scores was the opposite that of the HRR scores: 
participants in the eFP exhibited higher mean SCR. These results are indicative of 
complicated mechanisms underlying the processes involved in this study. 
We anticipated menstrual phase moderating the relationship between PTSD and 
performance on the loud tones task. However, the results for PTSD x menstrual phase 
interactions were mostly null, with one exception for EMG trials to habituation. Contrary 
to our hypotheses, the trauma control group on average took more trials to reach 
habituation than participants with PTSD in both menstrual cycle phases. However, these 
group differences were greater in the mid-luteal phase as compared to the early follicular 
phase. This partially supports the idea that the luteal phase is a period of vulnerability for 
women with PTSD. For women without PTSD, high levels of estradiol could be 
protective, which is supported by the trauma controls performing worse (requiring more 
trials to reach habituation) on this task during the follicular phase. Estradiol and 
progesterone levels were low at the eFP, a healthy woman’s period of vulnerability, while 
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high levels of estradiol and progesterone in the mLP created vulnerability in women with 
PTSD. This fits with the aforementioned rationale regarding the different effects of 
estradiol and progesterone on healthy women compared to women with PTSD. 
Analyses also examined the impact of order of testing, i.e., if performing the loud 
tones task in the follicular or luteal phase first influenced performance on the task in the 
second session. When participants were first tested in the follicular phase, they required 
more trials to reach habituation for SCR when in the follicular phase than in the luteal 
phase in the second session. When participants were tested in the luteal phase first, they 
required more trials to reach habituation for SCR in the luteal phase than the follicular. 
The same pattern was observed for mean EMGR scores: participants tested first in the 
follicular phase had higher mean EMGR in the follicular phase than in the luteal phase in 
the second session, and participants tested in the luteal phase first had higher mean 
EMGR in the luteal phase than in the follicular phase in the second session. These effects 
may have been due to the unfamiliarity of the task in the first session and subsequent 
preparedness for the second session. 
Table 12. Summary of Results 
 
Measure Result 
Mean Heart Rate 
Response 
Participants had lower average heart rate reactivity to loud tones 
in the eFP than the mLP 
Mean Skin 
Conductance 
Participants had higher mean skin conductance reactivity in the 
eFP than the mLP, the opposite effect as with mean heart rate 
Skin Conductance 
Trials to Habituation 
Participants were more reactive and took more trials to reach 
habituation in session 3 compared to session 5 
Mean EMGR • Participants with PTSD were less reactive (lower mean 
EMGR) compared to participants in the trauma control group, 
contrary to our hypothesis 
• Participants tested in eFP first were more reactive (higher 
mean EMGR) in session 3 than mLP in session 5; participants 
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 tested in mLP first were more reactive in session 3 than in eFP 
in session 5 
EMG Trials to 
Habituation 
• Participants with PTSD were less reactive (fewer trials to 
reach habituation) than participants in the trauma control 
group, contrary to our hypothesis 
• Participants with PTSD were more reactive in the mLP and 
took more time to reach habituation than in the eFP; 
participants in the trauma control group were more reactive in 
the eFP compared to the mLP 
 
 
A number of factors may have contributed to this study’s relative lack of support 
for our initial hypotheses. First, this study may have been underpowered due to its 
relatively small sample size (n = 46). In addition, the ethnic/racial diversity of the sample 
may have also contributed to our study’s mostly null results. Previous studies found 
African Americans are often non-responders to skin conductance testing (Inslicht et al., 
2013) and considering the majority of the sample being African American the results for 
skin conductance may have been skewed due to this effect, in spite of clear non- 
responders having been removed from the sample. Perez Benitez et al. (2014) 
investigated PTSD in African Americans in a longitudinal study, citing higher rates of 
exposure to major traumatic events and higher lifetime prevalence rates of PTSD (8.7%) 
compared to whites (7.4%) as well as higher risk of developing PTSD (1.2 times higher 
compared to whites). The study found high rates of chronicity among African Americans 
with PTSD as well as high rates of comorbidity (such as with major depressive disorder 
(MDD)) and lower psychosocial functioning. These factors may also have affected 
performance on the loud tones task. Thus certain ethnic or demographic groups may be 
affected by traumatic events differently or have PTSD manifest in particular ways (such 
as with comorbid MDD); such patterns may have affected results as well. In future 
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studies with a larger sample it would be worthwhile to stratify by demographics to see if 
there are differing effects. 
Another consideration is the type of trauma experienced by each participant and 
the age at which the event happened. Maerker et al. (2004) demonstrated how different 
types of trauma might affect an individual differently as well as the age, building off the 
idea that PTSD as a disorder requires a certain maturity of thinking that children might 
not possess. The study showed experiencing a traumatic event in childhood (before age 
12) is related to higher rates of MDD than experiencing trauma as an adolescent (13 and 
older) while such an age-related difference wasn’t found for PTSD. Consideration of the 
duration of the traumatic event (chronic or an isolated incident) may also shed light on 
the interesting results found in this study. 
There are likely individual differences in PTSD symptom profiles. While 
hyperarousal is one of four primary symptoms, as with any condition there can be 
variance in the way the condition manifests. Some participants in the PTSD group may 
not have been as affected by hyperarousal as, for example, the re-experiencing symptoms 
and thus did not perform as poorly on the loud tones task as other members of the group. 
The contributions of psychosocial and environmental factors as well as comorbidity may 
affect how PTSD manifests in a given individual and thus how they perform on 
assessments like the loud tones task. 
Pietrzak et al. (2014) examined typologies of PTSD in the US adult population, 
finding three broad categories: Anxious-Re-experiencing, Dysphoric, and High 
Symptom. There were demographic differences between the categories: members of the 
45  
 
 
High Symptom group were more likely to be younger, Black or Hispanic, less educated, 
and having a lower income while those in the Anxious-Re-experiencing group were more 
likely to be Hispanic, less educated, and less likely to be widowed/separated/divorced. 
The authors ultimately suggest the nature of the trauma exposure is associated with 
different manifestations of PTSD symptoms – that certain exposures may give rise to 
unique clusters of symptoms that may be etiologically linked to the nature of the 
traumatic event (for instance, sexual assault, military combat was most often found in the 
Anxious-Re-experiencing group while loss of a loved one was most common in the 
Dysphoric group). 
Related to this is the idea of different phenotypes of PTSD on a molecular level. 
A problem in ALLO conversion and in the HPA axis or CRH functioning are contenders 
for underlying mechanisms of PTSD but they are not the only ones; another compound 
that may contribute to this is neuropeptide Y (NPY), which plays a role in anxiety and 
depression by contributing to maintaining emotional homeostasis (Heilig, 2004) by acting 
as an anxiolytic (Thorsell, 2010). NPY is in part regulated by estrogen via membrane- 
bound ERα-mediated signaling at hypothalamic NPY-synthesizing neurons, which leads 
to NPY inhibition (Dhillon & Belsham, 2011). It follows that high estrogen would inhibit 
NPY and subsequently reduce some of its anxiolytic effects and contribute to the 
imbalance of emotional homeostasis at points of the menstrual cycle when estrogen is 
high (the mLP). In addition, estradiol modulates CRH by binding at the PVN to an 
ERα/ERβ-cAMP regulatory element that result in upregulation of CRH mRNA 
(Lalmansingh & Uht, 2008). Considering the potentially protective effects of estrogen in 
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healthy women, this effect may only be valid in an individual whose emotional 
homeostasis is already imbalanced – an individual, for example, with PTSD. 
For some individuals with PTSD there may be a problem with ALLO, and in 
others it might be NPY, or CRH. In others, it might be a combination of molecular 
problems. While there are a number of possible mechanisms underlying PTSD, it is 
unclear if these are acquired malfunctions due to the traumatic event or inherent 
individual differences that created a window of vulnerability. Knowing the answer to this 
question would open up many avenues of therapy and treatment. However this is a 
comparatively far-off goal in the trajectory of PTSD research, given where we are at the 
present time and what remains to be understood first. 
Limitations of this study include: small sample size, the use of a traumatized 
control group as opposed to a healthy control group, the use of only two menstrual 
phases, characteristics of the sample, and that the DSM-IV-TR criteria (which was 
current at the time the data was collected) was used as opposed to the more recent DSM- 
5. 
Future avenues of research should include continuing to try and understand the 
significance of ALLO, the HPA axis, and the hormones involved in the menstrual cycle 
with regard to PTSD manifestation and symptom severity. Similar studies could be 
conducted on other symptoms attributed to PTSD in order to determine how women 
specifically are affected. Further investigation into the menstrual cycle and menstrual 
hormones with regard to the presentation of PTSD symptoms is needed by testing women 
at a variety of points in the cycle. Replication of these results with a larger and more 
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diverse sample is needed in order to ascertain if these results are replicable. Such studies 
should also adjust for changes in diagnostic criteria in the DSM-5. Future studies should 
look longitudinally at performance on the loud tones tasks between the fifteen tones and 
across multiple sessions. Future research also should examine the difference in 
performance on loud tones tasks between healthy individuals and trauma exposed 
individuals without a PTSD diagnosis. 
Additionally considering demographic studies and points mentioned here, it 
would be prudent to pursue studying more specific samples, such as African American 
women, inhabitants of specific communities and neighborhoods, and individuals exposed 
to specific types of trauma. If the ultimate goal is to improve treatment for individuals 
with PTSD as well as to understand how the disorder manifests, the research indicates a 
need to further investigate why PTSD affects certain groups of people disproportionately. 
It would also be beneficial to further investigate how specific types of trauma and 
duration of trauma exposure affect PTSD symptom presentation. 
There is limited evidence that menstrual cycle may moderate the association 
between PTSD and habituation of the O-EMG response on the loud tones task. There was 
somewhat more support for the impact on menstrual phase on reactivity across women 
with and without PTSD. Interestingly, the opposing pattern of results for heart rate and 
skin conductance suggest that sympathetic and parasympathetic reactivity may be 
differentially affected my menstrual cycle phase. Further research needs to be done in 
order to better understand the relationship between PTSD and the menstrual cycle, 
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particularly in consideration of the hormones involved in relation to timing of trauma and 
the laboratory experimentation. 
49  
 
 
REFERENCES 
 
 
Abdul-Hamid, W. K., & Hughes, J. H. (2014). Nothing New Under the Sun: Post- 
Traumatic Stress Disorders in the Ancient World. Early Science and Medicine, 19 
(6), 549-557. 
 
American Psychological Association. (n.d.). Beck Depression Inventory (BDI). Retrieved 
December 20, 2015, from http://www.apa.org/pi/about/publications. 
 
America Psycological Assciation. (n.d.). The State-Trait Anxiety Inventory (STAI). 
 
Retrieved December 20, 2015, from 
http://www.apa.org/pi/about/publications/caregivers/practice- 
settings/assessment/tools/trait-state.aspx. 
 
 
Arborelius, L., Owens, M. J., Plotsky, P. M., & Nemeroff, C. B. (1999). The Role of 
Corticotropin-Releasing Factor in Depression and Anxiety Disorders. Journal of 
Endocrinology, 160 (1), 1-12. 
 
Attardi, B. J., Zeleznik, A., Simhan, H., Ping Chio, J., Mattison, D. R., & Caritis, S. N. 
(2008). Comparison of Progesterone and Glucocorticoid Receptor Binding and 
Stimulation of Gene Expression by Progesterone, 17-alpha hydroxyprogesterone 
caproate (17-OHPC), and Related Progestins. American Journal of Obstetrics and 
Gynecology, 197 (6), 599.e1-588.e7. 
Beck, A.T., Steer, R.A., & Brown, G.K. (1996). Manual for the Beck Depression 
Inventory-II. San Antonio, TX: Psychological Corporation. 
50  
 
 
Bernstein, D. P., Fink, L., Handelsman, L., Foote, J., Lovejoy, M., Wenzel, K., Sapareto, 
E., & Ruggiero, J. (1994). Initial Reliability and Validity of a New Retrospective 
Measure of Child Abuse and Neglect. American Journal of Psychiatry, 161, (8), 
1132-1136. 
Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Charney, D. S., & Keane, 
 
T. M. (1995). Clinician-Administered PTSD Scale (CAPS). Retrieved from 
https://d3gqux9sl0z33u.cloudfront.net/AA/AT/gambillingonjustice- 
com/downloads/220173/Clinician-Administered_PTSD_Scale   CAPS_.pdf. 
 
Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Charney, D. S., & Keane, 
 
T. M. (1998). Clinician-Administered PTSD Scale for DSM-IV. National Center 
for PTSD. Retrieved from 
http://www.clintools.com/victims/resources/assessment/ptsd/protected/CAPSIV.p 
df. 
 
Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Gusman, F. D., Charney, 
 
D. S. and Keane, T. M. (1995), The development of a clinician-administered 
PTSD scale. Journal of Traumatic Stress, 8(1), 75–90. 
doi: 10.1002/jts.2490080106 
 
Breslau, N., Kessler, R. C., Chilcoat, H. D., Schultz, L. R., Davis, G. C., & Andreski, P. 
(1998). Trauma and Posttraumatic Stress Disorder in the Community: The 1996 
Detroit Area Survey of Trauma. Archive of General Psychiatry, 55 (7), 626-632. 
51  
 
 
Bryant, R. A., Felmingham, K. L., Silove, D., Creamer, M., O’Donnell, M., & 
McFarlane, A. C. (2011). The Association Between Menstrual Cycle and 
Traumatic Memories. Journal of Affective Disorders, 131 (1-3), 398-401. 
Calogero, A. E., Burrello, N., Bosboom, A. M., Garofalo, M. R., Weber, R. F., & 
D’Agata, R. (1999). Glucocorticoids Inhibit Gonadotropin-Releasing Hormone by 
Acting Directly at the Hypothalamic Level. Journal of Endocrinological 
Investigation, 22 (9), 666-670. 
Cahill, L., & McGaugh, J. L. (1998). Mechanisms of Emotional Arousal and Lasting 
Declarative Memory. Trends in Neuroscience, 21 (7), 294-299. 
Choi, D. C., Furay, A. R., Evanson, N. K., Ostrander, M. M., Ulrich-Lai, Y. M., & 
Herman, J. P. (2007). Bed Nucleus of the STria Terminalis Subregions 
Differentially Regulate Hypothalamic-Pituitary-Adrenal Axis Activity: 
Implications for the Integration of Limbic Inputs. The Journal of Neuroscience, 
27 (8), 2025-2034. 
Dhillon, S. S., & Belsham, D. D. (2011). Estrogen Inhibits NPY Secretion Through 
Membrane-Associated Estrogen Receptor (ER)-α in Clonal, Immortalized 
Hypothalamic Neurons. International Journal of Obesity, 35 (2), 198-207. 
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B.W. (2002). Structured Clinical 
Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. 
New York, NY: Biometrics Research, New York State Psychiatric Institute. 
Gallegos, A. M., Wolff, K. B., Streltzov, N. A., Adams, L. B., Carpenter-Song, E., 
Nicholson, J., & Stecker, T. (2014). Gender Differences in Service utilization 
52  
 
 
Among OEF/OIF Veterans with Posttraumatic Stress Disorder after a Brief 
Cognitive-Behavioral Intervention it Increase Treatment Engagement: A Mixed 
Methods Study. Women’s Health Issues, 25 (5), 542-547. 
Gillespie, C. F., & Nemeroff, C. B. (2005). Hypercortisolemia and Depression. 
 
Psychosomatic Medicine, 67 (1), S26-S28. 
 
Glover, E. M., Mercer, K. B., Norrholm, S. D., Davis, M., Duncan, E., Bradley, B., … 
Jovanovic, T. (2012). Inhibition of Fear is Differentially Associated with Cycling 
Estrogen Levels in Women. Journal of Psychiatry and Neuroscience, 30 (5), 341- 
348. 
Grillon, C. (2008). Models and Mechanisms of Anxiety: Evidence from Startle Studies. 
 
Psychopharmacology, 199 (3), 421-437. 
 
Gutner, C. A., Pineles, S. L., Griffin, M. G., Bauer, M. R., Weierich, M. R., & Resick, P. 
 
A. (2010). Physiological Predictors of Posttraumatic Stress Disorder. Journal of 
Traumatic Stress, 23 (6), 775-784. 
Heilig, M. (2004). The NPY System in Stress, Anxiety and Depression. Neuropeptides, 
38 (4), 213-224. 
Hyman, S. E. (2009). How Adversity Gets Under the Skin. Nature Neuroscience, 12 (1), 
214-243. doi:10.1038/nn0309-241 
Inslicht, S. S., Metzler, T. J., Garcia, N. M., Pineles, S. L., Milad, M. R., Orr, S. P., … 
Neylan, T. C. (2012). Sex Differences in Fear Conditioning in Posttraumatic 
Stress Disorder. Journal of Psychiatric Research, 47 (1), 64-71. 
53  
 
 
Kalin, N. H., Shelton, S. E., & Davidson, R. J. (2004). The Role of the Central Nucleus 
of the Amygdala in Mediating Fear and Anxiety in the Primate. The Journal of 
Neuroscience, 24 (24), 5506-5515. 
Kasckow, J. W., Baker, D., & Geracioti, Jr, T. D. (2001). Corticotropin-Releasing 
Hormone in Depression and Post-Traumatic Stress Disorder. Peptides, 22 (5), 
845-851. 
Keifer, Jr., O. P., Hurt, R. C., Ressler, K. J., & Marvar P. J. (2015). The Physiology of 
Fear: Reconceptualizing the Role of the Central Amygdala in Fear Learning. 
Physiology, 30 (5), 389-401. 
Kubany, E., Leisen, M., Kaplan, A. S., Watson, S. B., Haynes, S. N., Owens, J. A., & 
Burns, K. (2000). Development and preliminary validation of a brief broad- 
spectrum measure of trauma exposure: The Traumatic Life Events Questionnaire. 
Psychological Assessment, 12 (2) 210-224. 
Lalmansingh, A. S., & Uht, R. M. (2008). Estradiol Regulates Corticotropin-Releasing 
Hormone Gene (crh) Expression in a Rapid and Phasic Manner that Parallels 
Estrogen Receptor-α and -β Recruitment to a 3′,5′-Cyclic Adenosine 5′- 
Monophosphate Regulatory Region of the Proximal crh Promoter. Endocrinology, 
149 (1), 346-357. doi: 10.1210/en.2007-0372. 
Lebron-Milad, K., Graham, B. M., & Milad, M. R. (2012). Low Estradiol Levels: A 
Vulnerability Factor for the Development of Posttraumatic Stress Disorder. 
Biological Psychiatry, 72 (1), 6-7. 
54  
 
 
Lee, Y., & Davis, M. (1997). Role of the Hippocampus, the Bed Nucleus of the Stria 
Terminalis, and the Amygdala in the Excitatory Effect of Corticotropin-Releasing 
Hormone on the Acoustic Startle Reflex. The Journal of Neuroscience, 17 (16), 
6434-6446. 
Lei, K., Chen, L, Georgiou, E. X., Sooranna, S. R., Khanjani, S., Brosens, J. J., … 
Johnson, M. R. (2012). Progesterone Acts via the Nuclear Glucocorticoid 
Receptor to Suppress IL-1-Beta-Induced COX-2 Expression in Human Term 
Myometrial Cells. PLoS ONE, 7 (11): e50167. 
Maercker, A., Michael, T., Fehm, L., Becker, E. S., & Jurgen, M. (2004). Age of 
Traumatization as a Predictor of Post-Traumatic Stress Disorder or Major 
Depression in Young Women. British Journal of Psychiatry, 184, 482-487. 
Mahan, A. L., & Ressler, K. J. (2012). Fear conditioning, Synaptic Plasticity, and the 
Amygdala: Implications for Posttraumatic Stress Disorder. Trends in 
Neuroscience, 35 (1), 24-35. 
Makino, S., Shibasaki, T., Yamauchi, N., Nishioka, T., Mimoto, T., Wakabayashi, I., … 
Hashimoto, K. (1999). Psychological Stress Increased Corticotropin-Releasing 
Hormone mRNA and Content in the central Nucleus of the Amygdala but not in 
the Hypothalamic Paraventricular Nucleus in the Rat. Brain Research, 850 (1-2), 
136-143. 
McIntyre, C. K., & Roozendaal, B. (2007). Adrenal Stress Hormones and Enhanced 
Memory for Emotionally Arousing Experiences. In F. Bermudez-Rattoni (Ed)., 
55  
 
 
Neural Plasticity and Memory: From Genes to Brain Imaging. Boca Raton, Fl: 
CRC Press/Taylor & Francis. 
Measurement Instrument Database for the Social Sciences. (n.d.). Childhood Trauma 
Questionnaire. Retrieved December 20, 2015, from 
http://www.midss.org/content/childhood-trauma-questionnaire. 
Metzger, L. J., Orr, S. P., Berry, N. J., Ahern, C. E., Lasko, N. B., & Pitman, R. K. 
(1999). Physiologic Reactivity to Startling Tones in Women with Posttraumatic 
Stress Disorder. Journal of Abnormal Psychology, 108(2), 347-352. 
Milad, M. R., Goldstein, J. M., Orr, S. P., Wedig, M. M., Klibanski, A., Pitman, R. K., & 
Rauch, S. L. (2006). Fear Conditioning and Extinction: Influence of Sex and 
Menstrual Cycle in Healthy Humans. Behavioral Neuroscience, 120 (5), 1196- 
1203. 
Milad, M. R., Rosenbaum, B. L., & Simon, N. M. (2014). Neuroscience of Fear 
Extinction: implications for Assessment and Treatment of Fear-Based and 
Anxiety Related Disorders. Behaviour Research and Therapy, 62 (1), 17-23. 
Milad, M. R., Zeidan, M. A., Contero, A., Pitman, R. K., Klibanski, A., Rauch, S. L., & 
Goldstein, J. M. (2010). The Influence of Gonadal Hormones on Conditioned 
Fear Extinction in Healthy Humans. Neuroscience, 168 (1), 652-658. 
Morgan, C. M., Grillon, C., Lubin, L., & Southwick, S. M. (1997). Startle Reflex 
Abnormalities in Women With Sexual Assault-Related Posttraumatic Stress 
Disorder. American Journal of Psychiatry, 154 (8), 1076-1080. 
56  
 
 
Nagaya, N., Acca, G. M., & Maren, S. (2015). Allopregnanolone in the Bed Nucleus of 
the Stria Terminalis Modulates Contextual Fear in Rats. Frontiers in Behavioral 
Neuroscience, 9 (205), doi: 10.3389/fnbeh.2015.00205. 
National Center for PTSD. (2000, November). CAPS Instruction Manual. Retrieved 
December 20, 2015, from http://vaww.ptsd.va.gov/docs/CAPSmanual.pdf. 
National Center for PTSD. (2015, November 9). Clinician-Administered PTSD Scale for 
DSM-5 (CAPS-5). Retrieved November 20, 2015, from 
http://www.ptsd.va.gov/professional/assessment/adult-int/caps.asp. 
National Center for PTSD. (2015, August 13). History of PTSD. Retrieved January 6, 
2016, from http://www.ptsd.va.gov/public/PTSD-overview/basics/history-of-ptsd- 
vets.asp. 
 
National Center for PTSD. (2015, November 24). Life Events Checklist for DSM-5 (LEC- 
5). Retrieved December 20, 2015, from 
http://www.ptsd.va.gov/professional/assessment/te- 
measures/life_events_checklist.asp. 
 
National Center for PTSD. (2015, August 13). Symptoms of PTSD. Retrieved January 6, 
2016, from http://www.ptsd.va.gov/public/PTSD- 
overview/basics/symptoms_of_ptsd.asp 
 
National Center for PTSD. (2014, January). Using the PTSD Checklist for DSM-IV 
(PCL). Retrieved December 20, 2015, from 
http://www.ptsd.va.gov/professional/pages/assessments/assessment-pdf/PCL- 
handout.pdf. 
57  
 
 
Nijsen, M. J. M. A., Croiset, G., Diamant, M., De Wied, D., & Wiegant, V. M. (2000). 
CRH Signalling in the Bed Nucleus of the Stria Terminalis is Involved in Stress- 
Induced Cardiac Vagal Activation in Conscious Rats. Neuropsychopharmacology, 
24 (1), 1-10. 
Nillni, Y. I., Pineles, S. L., Patton, S. C., Rouse, M. H., Sawyer, A. T. , & Rasmusson, A. 
 
M. (2015). Menstrual Cycle Effects on Psychological Symptoms in Women with 
PTSD. Journal of Traumatic Stress, 28 (1), 1-7. 
Nillni Y. I., Toufexis, D. J., & Rohan, K. J. (2011). Anxiety Sensitivity, the Menstrual 
Cycle, and Panic Disorder: a Putative Neuroendocrine and Psychological 
Interaction. Clinical Psychology Review, 31 (7), 1183-1191. 
Orr, S. P., Lasko, N. B., Macklin, M. L., Pineles, S. L., Chang, Y., & Pitman, R. K. 
(2012). Predicting Post-Trauma Stress Symptoms from Pre-Trauma 
Psychophysiologic Reactivity, Personality Traits and Measures of 
Psychopathology. Biology of Mood & Anxiety Disorders, 2 (8), 
http://doi.org/10.1186/2045-5380-2-8. 
Orr, S. P., Lasko, N. B., Shalev, A. Y., & Pitman, R. K. (1995). Physiologic Responses to 
Loud Tones in Vietnam Veterans with Posttraumatic Stress Disorder. Journal of 
Abnormal Psychology, 104 (1), 75-82. 
Orr, S. P., Metzger, L. J., Lasko, N. B., Macklin, M. L., Peri, T., & Pitman, R. K. (2000). 
 
De Novo Conditioning in Trauma-Exposed Individuals With and Without 
Posttraumatic Stress Disorder. Journal of Abnormal Psychology, 109 (2),290-298. 
58  
 
 
Orr, S. P., Solomon, S., Peri, T., Pitman, R. K., & Shalev, A. Y. (1997). Physiologic 
Responses to Loud Tones in Israeli Veterans of 1973 Yom Kippur War. 
Biological Psychiatry, 41 (3), 319-326. 
 
Perez Benitez, C. I., Sibrava, N. J., Kohn-Wood, L., Bjornsson, A. S., Zlotnick, C., 
Weisberg, R., & Keller, M. B. (2014). Posttraumatic Stress Disorder in African 
Americans: A Two Year Follow-Up Study. Psychiatry Research, 220 (1-2), 376- 
383. 
Pietrzak, R. H., el-Gabalawy, R., Tsai, J., Sareen, J., Neumeister, A., & Southwick, S. M. 
(2014). Typologies of Posttraumatic Stress Disorder in the U.S. Adult Population. 
Journal of Affective Disorders, 162, 102-106. 
Pinna, G., & Rasmusson, A. M. (2014). Ganaxolone Improves Behavioral Deficits in a 
Mouse Model of Post-Traumatic Stress Disorder. Frontiers in Cellular 
Neuroscience, 1 (8), 1-11. 
Pineles, S. L., Nillni, Y. I., King, M. W., Patton, S. C., Bauer, M. R., Mostoufi, S. M., … 
Orr, S. P. (in press). Extinction Retention and the Menstrual Cycle: Different 
Associations for Women with Posttraumatic Stress Disorder. Journal of Abnormal 
Psychology. 
Plotsky, P., Owens, M. J., & Nemeroff, C. B. (1995). Neuropeptide Alterations in 
Affective Disorders. In F. E. Bloom & D. J. Kupfer (Eds). Psychopharmacology: 
The Fourth Generation of Progress (971-981). New York, NY: Raven Press. 
Rajbhandari, A. K., Baldo, B. A., & Bakshi, V. P. (2015). Predator Stress-Induced CRF 
Release Causes Enduring Sensitization of Basolateral Amygdala Norepinephrine 
59  
 
 
Systems that Promote PTSD-Like Startle Abnormalities. Journal of Neuroscience, 
35 (42), 14270-14285. 
Rasmusson, A. M., Pinna, G., Paliwal, P., Weisman, D., Gottschalk, C., Charney, D., … 
Guidotti, A. (2006). Decreased Cerebrospinal Fluid Allopregnanolone Levels in 
Women with Posttraumatic Stress Disorder. Biological Psychiatry, 60 (7), 704- 
713. 
Schumacher, M., Hussain, R., Gago, N., Oudinet, J., Mattern, C., & Ghoumari, A. M. 
(2012). Progesterone Synthesis in the Nervous System: Implications for 
Myelination and Myelin Repair. Frontiers in Neuroscience, 6 (10), 1-22. 
SCID Frequently Asked Questions. (n.d.). Retrieved December 20, 2015, from 
http://www.scid4.org/faq/scidfaq.html. 
Shalev, A. Y., Orr, S. P., Peri, T., Schreiber, S., & Pitman, R. K. (1992). Physiologic 
Responses to Loud Tones in Israeli Patients with Posttraumatic Stress Disorder. 
Archives of General Psychiatry.49 (11), 870-875. 
Shalev, A. Y., Peri, T., Orr, S. P., Bonne, O., & Pitman, R. K. (1997). Auditory Startle 
Responses in Help-Seeking Trauma Survivors. Psychiatry Research, 69 (1997), 1- 
7. 
Shin, L. M., Rauch, S. L., & Pitman, R. K. (2006). Amygdala, Medial Prefrontal Cortex, 
and Hippocampal Function in PTSD. Annals of the New York Academy of 
Sciences, 1071 (1), 67-79. 
60  
 
 
Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. (1983). 
 
Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting 
Psychologists Press. 
Swaab, D. F. (2007). Sexual Differentiation of the Brain and Behavior. Best Practice & 
Research Clinical Endocrinology & Metabolism, 21 (3), 431-444. 
Thorsell, A. (2010). Brain Neuropeptide Y and Corticotropin-Releasing Hormone in 
Mediating Stress and Anxiety. Experimental Biology and Medicine, 235 (10), 
1163-1167. 
Uzunova, V., Ceci, M., Kohler, C., Uzunov, D. P., & Wrynn, A. S. (2003). Region- 
Specific Dysregulation of Allopregnanolone Brain Content in the Olfactory 
Bulbectomized Rat Model of Depression. Brain Research, 976 (1), 1-8. 
Walsh, K., Nugent, N. R., Kotte, A., Amstadter, A. B., Wang, S., Guille, C., … Resnick, 
 
H. S. (2013). Cortisol at the Emergency Room Rape Visit as a Predictor of PTSD 
and Depression Symptoms Over Time. Psychoneuroendocrinology, 38 (11), 
2520-2528. 
Weathers, F. W., Ruscio, A. M., & Keane, T. M. (1999). Psychometric Properties of Nine 
Scoring Rules for the Clinician Administered Posttraumatic Stress Disorder Scale. 
Psychological Assessment, 11 (2), 124-133. 
Weathers, F.W., Litz, B.T., Herman, J.A., Huska, J.A., & Keane, T.M. (1993). The PTSD 
Checklist (PCL): Reliability, validity and diagnostic utility. Paper presented at the 
9th Annual Conference of the ISTSS, San Antonio. 
61  
 
 
Whirledge, S., & Cidlowski, J. A. (2010). Glucocorticoids, Stress, and Fertility. Minerva 
Endocrinology, 35 (2), 109-125. 
Yajie, S., Hunt, S., & Sah, P. (2015). Norepinephrine and Corticotropin-Releasing 
Hormone: Partners in the Neural Circuits that Underpin stress and Anxiety. 
Neuron, 87 (3), 468-470. 
62  
 
 
CURRICULUM VITAE 
 
Aneline Amalathas 
Address: 8 Nira Avenue, Apt 3, Jamaica Plain, MA, 02130 
Phone: (845) 269 5161 • Email: anelineamalathas@gmail.com, anelinea@bu.edu • 
Birth Year: 1992 
 
Education 
Boston University School of Medicine August 2014 - Present 
Graduate Medical Sciences Division 
MS in Medical Sciences (anticipated graduation: 2016) 
 
New York University in London, UK January 2012 – May 2012 
 
New York University August 2010 – May 2014 
Bachelor of Arts in Psychology; Pre-Med track 
Minors in Medieval and Renaissance Studies and Physics 
 
Volunteer Experience 
VA Boston – National Center for PTSD Jamaica Plain, MA 
Research Assistant October 2015 – Present 
• Worked on Master’s Thesis (“Trauma and Psychophysiologic Reactivity”) under the 
supervision of Dr. Suzanne Pineles 
 Ran data analyses using SPSS, R 
 Managed data for large studies 
 Helped write papers, research grant proposals, and presentations 
 
Beth-Israel Hospital – Philips Ambulatory Care Center New York, NY 
Post-Op Recovery Room Volunteer October 2013 – February 2014 
• Stripped charts, entered patient information at nurse’s station 
• Retrieved patients’ belongings, escorted patients in wheelchairs out of hospital 
 Performed tasks and ran errands for the nurses; delivered/retrieved charts to and from 
Pre-Op and Post-Op 
 
The Motivation Lab at NYU New York, NY 
Research Assistant January 2013 – May 2014 
 Operated multiple psychophysiological experiments with BioPac 
 Acted as experimenter for multiple psychophysiological experiments 
 Performed scheduling and recruiting; contacted participants following sign-up regarding 
experimental protocol; managed scheduling conflicts 
 Organized information regarding past experiments and participants 
 Performed data entry, coded experimental results for analysis 
63  
 
 
VIDA Volunteer Travel Nicaragua and Costa Rica 
Medical Volunteer January 2012 
 Worked in free clinics in Costa Rica and Nicaragua 
 Helped local physicians diagnose and treat patients 
o Worked in groups to assess patients’ symptoms and differentially diagnose their 
conditions, gathered information on vital signals and medical history 
o Presented personal information, symptoms, and diagnoses to a physician for 
each patient 
o Explained to patient how to use the medicines prescribed by the physician 
o Worked the pharmacy station by filling prescriptions 
 
St. Francis Hospital Poughkeepsie, NY 
Emergency Room Volunteer July 2011 – August 2011 
 Organized and cleaned EMT storage room 
 Kept patient and trauma rooms clean and stocked; stripped and redressed beds, 
restocked blanket incubator 
 
Work Experience 
Rosie’s Place Roxbury, MA 
Fill-In Part-Time Employee October 2015 – Present 
 Worked at the front desk with other employees 
o Answered phone calls, took messages, processed incoming mail, sent faxes, 
made copies, provided information and help to women at the shelter 
 Worked in the food pantry with other employees 
o Input information of women using the service, trained and supervised 
volunteers, kept the pantries organized and well-stocked, processed deliveries, 
cleaned and locked up pantries at the end of the night 
 Occasionally worked with the Outreach Van on trips to Roxbury, Dorchester, and other 
neighborhoods 
o Distributed clothes, toiletries, water, snacks, blankets, coats 
o Provided information about the services at Rosie’s Place to women who came to 
the Van 
 
Research 
VA Boston – National Center for PTSD (Jamaica Plain) October 2015 – Present 
• Master’s Thesis: “Trauma and Psychophysiologic Reactivity” 
o Examining how PTSD in women is affected by menstrual phase with regard to 
performance on loud tones task as an operationalization of startle reactivity 
 Principle investigator: Dr. Suzanne L. Pineles 
 
NYU Department of Psychology October 2013 – May 2015 
 Course: Lab in Social and Personality Psychology 
o In a small group conducted correlational archival study of visual representations 
of American politicians of color by national news sources 
o Wrote scientific paper on findings, presented to class 
64  
 
 
 Continued social psychology research at NYU during Spring 2014 studying media bias 
and representations of skin tone of politicians of color, previously studied in Lab in Social 
and Personality, in the Social Perception, Action, and Motivation Lab 
• Research team granted the Dean’s Undergraduate Research Fund Grant in Spring 2014 
 Team gave talk on research findings at NYU Undergraduate Research Conference in 
April 2014, was awarded for Best Panel 
 Team gave talk on research findings at NYU Summer Student Conference sponsored by 
the NYU Arts & Sciences Diversity Initiative 
 Research project ongoing at NYU; plan to seek publication of findings in the near future 
 
Awards 
• Dean’s List for Academic Year: 2013 – 2014 
• Dean’s Undergraduate Research Fund Grant for Spring 2014 
 NYU Undergraduate Research Conference 2014: Best Panel 
 
Presentations 
 Alpert, A., Amalathas, A., & Menon, S. (2014, April 25) 256 Shades of Gray: How 
Skin Tone Colors Perceptions of Politicians in the Media. Paper presented at New 
York University Undergraduate Research Conference, New York, NY. 
 Alpert, A., Amalathas, A., & Menon, S. (2014, July 11) 256 Shades of Gray: How 
Skin Tone Colors Perceptions of Politicians in the Media. Paper presented at New 
York University Summer Student Conference, New York, NY. 
 
Publications 
 Alpert, A., Amalathas, A., & Menon, S. (2014) 256 Shades of Gray: How Skin 
Tone Colors Perceptions of Politicians in the Media. Inquiry: A Journal of 
Undergraduate Research, 18, 40-41. 
 
Other Experiences 
 Clinical 
o Shadowing 
Summer 2011 
• Shadowed local physicians in multiple fields of medicine at St. Francis 
Hospital and Vassar Brothers Hospital in Poughkeepsie, NY 
 Languages 
o Fluent in Romanian: native speaker 
o Knowledge of Spanish: took university-level courses up to/including 
Intermediate II; used Spanish language knowledge in clinical work during VIDA 
Volunteer service trip to Central America 
 Memberships 
o NYU division of the American Medical Students Association 
o Boston Student Health Activist Community 
 Skills 
o Excellent communication and writing skills 
65  
 
 
o Experience working in group settings and in one-on-one interactions in 
professional and academic settings 
o Academic writing: have written scientific papers in APA and MLA formats for 
psychology and biology as well as papers in non-scientific disciplines 
o Statistics: Excel, SPSS; currently learning R 
o Highly critical reader of information 
o Creative writing: self-published fiction novel in Fall 2006; writes novels, short 
stories in spare time 
o Other interests: history, movies and TV, books, writing, literature, art, social 
justice and activism, bubble tea 
